Study investigated Lactobacillus gasseri in patients with mild to moderate active ulcerative colitis.
About this study
In this research project, we are testing a new treatment for mild to moderate active ulcerative colitis. The new treatment uses a type of bacteria called KBL697 (Lactobacillus gasseri). The study aims to learn how effective and safe the bacteria is in the treatment of people with mild to moderate active ulcerative colitis.
Ethics
All research in Australia involving human participants is reviewed by an independent group called a Human Research Ethics Committee (HREC). The ethical aspects of this research study have been approved by the Royal Melbourne Hospital HREC.
This study is being carried out according to the National Statement on Ethical Conduct in Human Research (2007). This statement protects the interests of people who agree to participate in human research studies.